What proportion of patients with IBDU are eventually reclassified as CD or UC

What is known

- A pediatric meta-analysis pooled 50% reclassification overall, with 30% to UC and 20% to CD. ¹ - A Scottish pediatric cohort (median ~10.5 years) reclassified 60%: 30% to UC and 29% to CD. ² - In an adult European cohort, cumulative reclassification was 19% at 1 year, 26% at 5 years, and 32% at 10 years; a French study reported 17%, 41%, and 54% at those timepoints. ³ - Reclassification increases with longer follow-up, and among those reclassified, most become UC while roughly 10-30% behave like CD. ⁴ - Older reviews report up to 80% eventually reclassified to CD or UC and up to 20% to non-IBD, though a small subset remains IBDU beyond 10 years. ^5,6

What is unknown / caveats

- Short prospective follow-up (~6 months) shows ~84% remain unclassified, while long-term follow-up shows the majority reclassified - Older sources cite reclassification 'up to 80%' whereas recent cohorts report ~32-60% - Proportions depend heavily on follow-up duration and whether pediatric or adult populations - Some cohorts note patients not reclassified may not have had regular colonoscopy, potentially underestimating reclassification - A portion of patients are reclassified as non-IBD rather than UC or CD - There is no single figure; reported proportions span roughly one-third to 80% depending largely on follow-up time.

## References

1. Bolia R, Goel AD. SYSTEMATIC REVIEW AND META - ANALYSIS OF THE FREQUENCY AND RE-CLASSIFICATION TRENDS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE - UNCLASSIFIED. Arq Gastroenterol. 2022;59(4):531-539. PMID: 36515348.

2. Wands DIF, Gianolio L, Cameron F, Hansen R, Russell RK, Wilson DC. Pediatric Inflammatory Bowel Disease Type Unclassified: A Nationwide Cohort Study in Scotland With up to 20 Years Follow-up Shows Reclassification in the Majority and Mild Course in Those Whose Diagnosis Is Unchanged. Inflamm Bowel Dis. 2025;31(2):313-320. PMID: 39321100.

3. Balogh F, Gonczi L, Angyal D, Golovics PA, Pandur T, David G, Erdelyi Z, Szita I, Ilias A, Lakatos L, Lakatos PL. Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort. World J Gastroenterol. 2025;31(33):109800. PMID: 40933456.

4. [No authors listed]. Clinical features of inflammatory bowel disease unclassified: a case-control study. BMC Gastroenterol. 2024;24(1):105. PMID: 38481157.

5. [No authors listed]. What is the incidence, prevalence, and natural history of indeterminate colitis?. Inflamm Bowel Dis. 2008;14 Suppl 2:S159-60. PMID: 18816765.

6. Wells AD, McMillan I, Price AB, Ritchie JK, Nicholls RJ. Natural history of indeterminate colitis. Br J Surg. 1991;78(2):179-81. PMID: 2015465.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

---

_Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct._